Cell line · CVCL_0526
SK-MEL-28
Cancer cell line, Homo sapiens. Cutaneous melanoma. 161 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SK-MEL-28. Cell lines, record CVCL_0526. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0526
On this page
Cell line
As Cellosaurus gives it.
- Name
- SK-MEL-28
- Accession
- CVCL_0526
- RRID
- RRID:CVCL_0526
- Synonyms
- SK-Mel-28, SK.MEL.28, SK-MEL 28, SK MEL-28, SK MEL 28, SK Mel 28, SKMel-28, SKMEL-28, SK-MEL28, SK-Mel28, SK Mel28, SKMEL28, SKMel28, SKmel28, SKML-28, SK28, AU-Mel, P-36, P36
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 51Y
- Category
- Cancer cell line
- Diseases
- Cutaneous melanoma (NCIt C3510)
- Derived from
- Skin (in situ)
- Cell type
- Melanocyte of skin
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers161
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Berberine and Etoposide Exert Synergistic Anticancer Effects in A431 Epidermoid Carcinoma Cells. | ACS Omega | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genotype-driven tumor ecosystems drive immune evasion and immunotherapy resistance in melanoma. | Mol Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Recombinant BaMtx Preserves the Biological Properties of a Lys49 Phospholipase A2 from Bothrops atrox and Reveals Differential Responses in Tumor and Non-Tumor Cell Models. | Toxins (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells. | Front Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MITF maintains genome stability in nonmelanocyte lineages. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Global analysis of cancer cell responses to USP9X inhibition. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 161
See all 161 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | OCM-3 | CVCL_6937 | Has a recorded problem | Cell lines |
| Derived from it | OCM-8 | CVCL_6938 | Has a recorded problem | Cell lines |
| Derived from it | SK-MEL-28-Luc | CVCL_J267 | Cell lines | |
| Derived from it | SK-MEL-28-VR | CVCL_AP99 | Cell lines | |
| Derived from it | SK-MEL-28DDR1-PLXAZD | CVCL_IM75 | Cell lines | |
| Derived from it | SK-MEL-28R1-PLX | CVCL_IM76 | Cell lines | |
| Derived from it | SKMEL28-SLC13A3-KO-c3 | CVCL_D4WQ | Cell lines | |
| Derived from it | SKMEL28-SLC13A3-KO-c4 | CVCL_D4WR | Cell lines |
Cell banks10
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-72 | ATCC | |
| AddexBio | C0020001/66 | Cellosaurus | |
| BCRJ | 0289 | BCRJ | |
| CLS | 300337 | CLS | |
| CancerTools | 161917 | CancerTools | |
| EDITGENE | EDC00372 | EDITGENE | |
| ICLC | HTL99010 | ICLC | |
| NCI-DCTD | SK-MEL-28 | Cellosaurus | |
| RCB | RCB1930 | Discontinued | Cellosaurus |
| TKG | TKG 0333 | Discontinued | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0526
GET https://conductscience.org/api/cell-lines/v1/CVCL_0526/papers?page=2